SUSPEND Act Gets Moving
Client Alert | less than 1 min read | 11.13.13
On October 29, the House Oversight Committee passed out of committee the Stop Unworthy Spending, or SUSPEND, Act, legislation that would, effective FY2017, consolidate agency suspension and debarment offices into a single "Board of Suspension and Debarment" at GSA and unify the procurement and non-procurement suspension and debarment regulations, among other changes. The SUSPEND Act contains exceptions to allow offices of major agencies to remain in place in certain specified circumstances and for the SBA to retain its authority to suspend or debar entities for misrepresentation of small business status.
Contacts
Insights
Client Alert | 4 min read | 01.07.26
On December 17, 2025, the U.S. Food and Drug Administration (FDA) issued a request for information (RFI) on a proposal designed to help the FDA engage more directly with innovative, venture-backed companies focused on biotechnology, medical devices, AI, and regulatory technology.[i]The RFI includes 19 questions, with responses due by 2:00 p.m. ET on January 18, 2026.
Client Alert | 3 min read | 01.07.26
CMMC for AI? Defense Policy Law Imposes AI Security Framework and Requirements on Contractors
Client Alert | 3 min read | 01.07.26
New Year, Same CIPA Uncertainty – When Will the Appellate Courts Enter the Chat?
Client Alert | 11 min read | 01.07.26
